Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors

被引:5
|
作者
Pfaffendorf, M
Batink, HD
Tränkle, C
Mohr, K
van Zwieten, PA
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Bonn, Dept Pharmacol & Toxicol, D-53121 Bonn, Germany
来源
JOURNAL OF AUTONOMIC PHARMACOLOGY | 2000年 / 20卷 / 01期
关键词
D O I
10.1046/j.1365-2680.2000.00163.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1 The aim of the present investigation was to analyse whether three prototype allosteric modulators of ligand binding to muscarinic receptors, i.e. alcuronium, gallamine, and the alkane-bis-ammonium compound W84 (hexane-1,6-bis[dimethyl-3'-phthalimidopropylammonium bromide]), may have allosteric effects on radioligand-binding characteristics at other G-protein-coupled receptors, such as cerebral A, adenosine receptors (G(i)-coupled), cardiac left ventricular alpha (1)-adrenoceptors (G(q)), and beta -adrenoceptors (G(s)). 2 The modulators were applied at concentrations known to be high with regard to the allosteric delay of the dissociation of the antagonist [H-3]-N-methylscopolamine (NMS) from muscarinic M-2-receptors: 30 mu mol l(-1) W84, 30 mu mol l(-1) alcuronium, 1000 mu mol l(-1) gallamine. As radioligands, we used the adenosine A(1)-receptor ligand [H-3]-cyclopentyl-dipropylxanthine (CPX), the alpha (1)-adrenoceptor ligand [H-3]-prazosin (PRAZ), and the beta -adrenoceptor ligand (-)-[I-125]-iodocyanopindolol (ICYP). Allosteric actions on ligand dissociation and the equilibrium binding were measured in the membrane fractions of rat whole forebrain (CPX) and of rat cardiac left ventricle (PRAZ, ICYP, NMS), respectively. 3 CPX and PRAZ showed a monophasic dissociation with half-lives of 5.88 +/- 0.15 and 12.27 +/- 0.46 min, respectively. In the case of CPX, neither the binding at equilibrium nor the dissociation characteristics were influenced by the allosteric agents. With PRAZ, the binding at equilibrium remained almost unaltered in the presence of W84, whereas it was reduced to 36 +/- 2% of the control value with alcuronium and to 42 +/- 2% with gallamine. The dissociation of PRAZ was not affected by W84, whereas it was moderately accelerated by alcuronium and gallamine. In the case of ICYP, the binding at equilibrium was not affected by the allosteric modulators. The dissociation of ICYP was slow, and after 3 h, more than 50% of the radioligand was still bound, so that a reliable half-life could not be calculated. ICYP dissociation was not affected by W84. In the presence of alcuronium and gallamine, the dissociation curve of ICYP revealed an initial drop from the starting level, followed by the major phase of dissociation being parallel to the control curve. 4 In summary, the allosteric action of the applied agents is not a common feature of G-protein-coupled receptors and appears to be specific for muscarinic receptors.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [31] G-protein-coupled receptors and melanoma
    Lee, Hwa Jin
    Wall, Brian
    Chen, Suzie
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (04) : 415 - 428
  • [32] G-protein-coupled receptors and cancer
    Dorsam, Robert T.
    Gutkind, J. Silvio
    NATURE REVIEWS CANCER, 2007, 7 (02) : 79 - 94
  • [33] Deorphanization of G-protein-coupled receptors
    Parmentier, M.
    Detheux, M.
    GPCRS: FROM DEORPHANIZATION TO LEAD STRUCTURE IDENTIFICATION, 2007, 2 : 163 - 186
  • [34] FINGERPRINTING G-PROTEIN-COUPLED RECEPTORS
    ATTWOOD, TK
    FINDLAY, JBC
    PROTEIN ENGINEERING, 1994, 7 (02): : 195 - 203
  • [35] Powdered G-Protein-Coupled Receptors
    Perera, Suchithranga M. D. C.
    Chawla, Udeep
    Brown, Michael F.
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2016, 7 (20): : 4230 - 4235
  • [36] Dimerization of G-protein-coupled receptors
    Dean, MK
    Higgs, C
    Smith, RE
    Bywater, RP
    Snell, CR
    Scott, PD
    Upton, GJG
    Howe, TJ
    Reynolds, CA
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4595 - 4614
  • [37] G-protein-coupled receptors and disease
    Perez, D
    RECEPTORS & CHANNELS, 2002, 8 (01): : 1 - 1
  • [38] Efficacy at G-protein-coupled receptors
    Kenakin, T
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (02) : 103 - 110
  • [39] G-protein-coupled receptors:: an update
    Fredholm, B. B.
    Hokfelt, T.
    Milligan, G.
    ACTA PHYSIOLOGICA, 2007, 190 (01) : 3 - 7
  • [40] DETECTION, QUANTITATION, AND VERIFICATION OF ALLOSTERIC INTERACTIONS OF AGENTS WITH LABELED AND UNLABELED LIGANDS AT G-PROTEIN-COUPLED RECEPTORS - INTERACTIONS OF STRYCHNINE AND ACETYLCHOLINE AT MUSCARINIC RECEPTORS
    LAZARENO, S
    BIRDSALL, NJM
    MOLECULAR PHARMACOLOGY, 1995, 48 (02) : 362 - 378